risks associated with semaglutide Frontiers SELECT Trial

46.3% Smoking Abstinence With GLP-1 In a clinical trial utilizing a GLP-1 receptor agonist combined with nicotine replacement therapy, 46.3% of participants successfully abstained from smoking after six weeks

Dr Jessie Phoon, an obstetrician and gynaecologist at Mount Elizabeth Fertility Centre, is also against using the drug to improve fertility

How We Review GLP-1 Providers: Our Price & Trust Transparency Score From June to August, 2025, we ran a survey to determine what people (like you!) look for and care about the most when it comes to choosing a GLP-1 provider

Its unclear whether they should be used together

Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans

PlexusDx patients can ask their healthcare provider which specific probiotic brands have the strongest evidence base for supporting GLP-1 therapy adaptation